Treat early, suppress fast!
In a new paper just published online in Journal of AIDS, EPIICAL researchers investigated the association between the timing of antiretroviral therapy (ART) initiation and time-to suppression among HIV-infected infants who initiated ART within the first 28 days of life.
The study showed as children treated within 7 days of life have a faster time to viral suppression, which may result in a favorable impact on the viral reservoir.
These data strongly support the potential benefits of starting ART within 7 days of birth even in comparison to starting from 8 to 28 days after birth.